Arena Pharmaceuticals, Inc. (ARNA) Earning

NASDAQ Currency in USD Disclaimer

$99.99

north_east NA Past Year
Day's range
$99.97
Day's range
$100

Arena Pharmaceuticals, Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
02/23/2022 Q4 2021 -$2.26 -$2.55 -0.29 $54,000
11/04/2021 Q3 2021 -$2.53 -$3.21 -0.68 $0
08/05/2021 Q2 2021 -$2.20 -$2.40 -0.2 $0
05/05/2021 Q1 2021 -$2.16 -$1.98 0.18 $0
02/23/2021 Q4 2020 -$1.85 -$2.10 -0.25 $37,000
11/09/2020 Q3 2020 -$1.87 -$1.69 0.18 $20,000
08/05/2020 Q2 2020 -$2.03 -$1.61 0.42 $0
05/07/2020 Q1 2020 -$2.28 -$2.00 0.28 $262,000
02/27/2020 Q4 2019 -$1.76 $3.00 M
11/08/2019 Q3 2019 -$1.46 $1.35 M
08/08/2019 Q2 2019 -$1.24 $1.02 M
05/09/2019 Q1 2019 $12.53 $801.06 M
02/28/2019 Q4 2018 $1.39 $8.65 M
11/08/2018 Q3 2018 -$0.70 $3.57 M
08/07/2018 Q2 2018 -$0.65 $3.99 M
05/09/2018 Q1 2018 -$0.80 $1.76 M
03/14/2018 Q4 2017 -$0.59 -$0.35 0.24 $273,000
11/08/2017 Q3 2017 -$0.86 $7.95 M
08/08/2017 Q2 2017 -$0.77 $6.49 M
05/09/2017 Q1 2017 -$0.72 -$0.90 -0.18 $6.62 M
 

Arena Pharmaceuticals, Inc. Earnings: FAQ's

When is Arena Pharmaceuticals, Inc.'s earnings date?

Arena Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 4th, 2022 based off last year's report dates.

How can I listen to Arena Pharmaceuticals, Inc.'s earnings conference call?

The conference call for Arena Pharmaceuticals, Inc.'s latest earnings report can be listened to online.

How can I read Arena Pharmaceuticals, Inc.'s conference call transcript?

The conference call transcript for Arena Pharmaceuticals, Inc.'s latest earnings report can be read online.

How much revenue does Arena Pharmaceuticals, Inc. generate each year?

Arena Pharmaceuticals, Inc. (:ARNA) has a recorded annual revenue of $54,000.

How much profit does Arena Pharmaceuticals, Inc. generate each year?

Arena Pharmaceuticals, Inc. (:ARNA) has a recorded net income of $54,000. Arena Pharmaceuticals, Inc. has generated $-11.33 earnings per share over the last four quarters.

What is Arena Pharmaceuticals, Inc.'s price-to-earnings ratio?

Arena Pharmaceuticals, Inc. (:ARNA) has a price-to-earnings ratio of -8.82 and price/earnings-to-growth ratio is -0.09.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED